1-month dual antiplatelet therapy post-stent implant benefits high bleeding risk patients
One month of dual antiplatelet therapy (DAPT) following stent implantation in high bleeding risk patients preserves ischaemic benefits and reduces bleeding risk. That’s the finding of late breaking…
Trial reports first successful results for heart failure with preserved ejection fraction
Empagliflozin reduces the risk of a composite of cardiovascular death or hospitalisation for heart failure in patients with heart failure and a preserved ejection fraction (HFpEF) with or…
Screening for atrial fibrillation could reduce risk of stroke
Screening for atrial fibrillation in 75- and 76-year-olds could reduce the risk of stroke, severe bleeding and death, according to a study at Karolinska Institutet in Sweden that…
Trial does not support early coronary angiography in cardiac arrest without ST elevation
Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients without ST-segment elevation is not superior to a delayed/selective approach, according to late breaking research presented at ESC Congress…
Continuous heart rhythm monitoring and treatment if indicated does not prevent stroke
Continuous heart rhythm monitoring – with anticoagulation if atrial fibrillation is detected – does not prevent strokes in those at risk. That’s the finding of late breaking research…